Futura Medical (GB:FUM) has released an update.
Futura Medical plc has announced that its leading sexual health product, Eroxon®, will be available for pre-order online in the US starting September 2024, with in-store availability following in October. The company specializes in innovative and clinically proven sexual health products and is set to meet the significant demand in the erectile dysfunction market. Eroxon stands out as the only over-the-counter topical gel for erectile dysfunction, promising to help men achieve an erection within ten minutes.
For further insights into GB:FUM stock, check out TipRanks’ Stock Analysis page.
